NCT01110954 is a Phase 2 clinical trial of PD L 506 in Breast Tumour, sponsored by photonamic GmbH & Co. KG.

Who is sponsoring NCT01110954?

NCT01110954 is sponsored by photonamic GmbH & Co. KG.

What drugs are being tested in NCT01110954?

Interventions in NCT01110954: PD L 506.

What condition does NCT01110954 study?

NCT01110954 studies Breast Tumour.

Is NCT01110954 still recruiting?

NCT01110954 is currently terminated. Last updated 4 April 2017.

Last reviewed 2017-04-04 · How we verify

NCT01110954

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fluorescence-guided Resection in Breast Cancer

Terminated Phase 2 Last updated 4 April 2017

What this trial tests

Phase 2 trial testing PD L 506 in Breast Tumour in 8 participants. Terminated before completion.

Timeline

31 May 2010

Primary endpoint
19 July 2012

20 December 2012

Quick facts

Lead sponsor	photonamic GmbH & Co. KG
Phase	Phase 2
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	diagnostic
Enrollment	8
Start date	31 May 2010
Primary completion	19 July 2012
Estimated completion	20 December 2012
Sites	1 location across Germany

Drugs / interventions tested

PD L 506 — full drug profile →

Conditions studied

Breast Tumour — all drugs for Breast Tumour →

Sponsor

photonamic GmbH & Co. KG — full company profile →

Who can join

18 and older, female only, with Breast Tumour. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an explorative phase II study to investigate the suitability of PD L 506 in the specific intra-operative detection of breast tumour tissue.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other photonamic GmbH & Co. KG trials

Trials by the same sponsor.

NCT03606122 — 5-ALA Patch-PDT of Actinic Keratosis on the Upper Extremities · Phase 2 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01110954 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by photonamic GmbH & Co. KG
Last refreshed: 4 April 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01110954.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing